REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy.
Wang H, Zhang SY, Wang S, Lu J, Wu W, Weng L, Chen D, Zhang Y, Lu Z, Yang J, Chen Y, Zhang X, Chen X, Xi C, Lu D, Zhao S.
Wang H, et al. Among authors: xi c.
Neuro Oncol. 2009 Dec;11(6):790-802. doi: 10.1215/15228517-2009-015.
Neuro Oncol. 2009.
PMID: 19289490
Free PMC article.